These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11761944)

  • 1. [Classification of degree of liver damage and cancer stage].
    Yamasaki S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():222-6. PubMed ID: 11761944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histological classification of hepatocellular carcinoma].
    Kojiro M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():203-15. PubMed ID: 11761942
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
    Maeda Y; Nishida M; Mori N; Tamesa T; Okada T; Tangoku A; Oka M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():401-5. PubMed ID: 11761981
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver resection (part I) -- anatomical basis, indication, and preoperative planning].
    Oldhafer KJ; Bourquain H; Stavrou GA
    Zentralbl Chir; 2006 Apr; 131(2):W22-33; W34-5. PubMed ID: 16612771
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 8. [Technical aspects of segment I resection of the liver].
    Ringe B; Canelo R; Schulze FP; Lorf T
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():269-71. PubMed ID: 9101852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and management of intrahepatic cholangiocarcinoma.
    Farges O; Fuks D
    Gastroenterol Clin Biol; 2010 Mar; 34(3):191-9. PubMed ID: 20202770
    [No Abstract]   [Full Text] [Related]  

  • 11. [E-cadherin].
    Kato M; Terada T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():195-200. PubMed ID: 11761940
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
    Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
    Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver.
    Harada K; Terada T; Nakanuma Y; Furukawa Y; Kurumaya H
    Am J Gastroenterol; 1993 Nov; 88(11):1968-9. PubMed ID: 8237956
    [No Abstract]   [Full Text] [Related]  

  • 15. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
    Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
    Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
    Roskams T
    Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete resection of the caudate lobe of the liver with tumor: technique and experience.
    Fan J; Wu ZQ; Tang ZY; Zhou J; Qiu SJ; Ma ZC; Zhou XD; Yu YQ
    Hepatogastroenterology; 2001; 48(39):808-11. PubMed ID: 11462929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary tumors of the liver.
    Colombari R; Tsui WM
    Semin Liver Dis; 1995 Nov; 15(4):402-13. PubMed ID: 8578323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepato-cholangiocarcinoma with diffuse metastases and hypercalcemia].
    Pérez Roldán F; Carretero L; Aguirre A; Bañares R; Casado M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1995 Oct; 87(10):743-7. PubMed ID: 8519543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.